Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12582023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantigen microarrays for multiplex characterization of autoantibody responses

  2002cited by this paper
• Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.

  2001cited by this paper
• De‐novo humoral immune responses to cancer‐associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma

  2001cited by this paper
• Autoimmune responses to mRNA binding proteins p62 and Koc in diverse malignancies.

  2001cited by this paper
• Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

  2001cited by this paper
• Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells

  2001cited by this paper
• Are all cancer genes equal?

  2001cited by this paper
• p53 Antibodies in the sera of patients with various types of cancer: a review.

  2000cited by this paper
• Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.

  2000cited by this paper
• Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein.

  2000cited by this paper
• A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development

  1999cited by this paper
• Why is Hu where? Shuttling of early-response-gene messenger RNA subsets.

  1999cited by this paper
• A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma

  1999cited by this paper
• Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.

  1998cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations.

  1998cited by this paper
• Characterization of human colon cancer antigens recognized by autologous antibodies

  1998cited by this paper
• Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.

  1998cited by this paper
• Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

  1997cited by this paper
• A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

  1997cited by this paper
• High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.

  1997cited by this paper
• Immune response to cyclin B1 in hepatocellular carcinoma

  1997cited by this paper
• Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

  1996cited by this paper
• Human tumor antigens recognized by T lymphocytes

  1996cited by this paper
• Immunity to Oncogenic Proteins

  1995cited by this paper
• Serum p53 antibodies as early markers of lung cancer

  1995cited by this paper
• Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride.

  1995cited by this paper
• Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

  1994cited by this paper
• A new LIM protein containing an autoepitope homologous to "senescent cell antigen".

  1994cited by this paper
• Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.

  1993cited by this paper
• Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma

  1993cited by this paper
• Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.

  1992cited by this paper
• Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

  1992cited by this paper
• Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

  1989cited by this paper
• Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

  1982cited by this paper

• A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection

  2025cites this paper
• The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma

  2024cites this paper
• Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers

  2024influential citation
• Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer

  2024cites this paper
• A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations

  2023cites this paper
• Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women

  2023cites this paper
• The Usefulness of the Ratio of Antigen–Autoantibody Immune Complexes to Their Free Antigens in the Diagnosis of Non-Small Cell Lung Cancer

  2023cites this paper
• ANA-HEp2 pattern evaluation in pancreatic cancer: What can the autoantibodies tell us?

  2022cites this paper
• Molecular and Circulating Biomarkers of Gastric Cancer

  2022cites this paper
• Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization

  2022cites this paper
• Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment

  2021cites this paper
• Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer

  2021cites this paper
• The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma

  2021cites this paper
• Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer

  2021cites this paper
• A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody‐antigen system

  2021cites this paper
• Autoantibodies in the diagnosis, prognosis, and prediction of colorectal cancer

  2021cites this paper
• Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer

  2021cites this paper
• Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma

  2021cites this paper
• Anti‐p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta‐analysis

  2020cites this paper
• Inducing multiple antibodies to treat squamous cell esophageal carcinoma

  2020cites this paper
• Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma

  2020cites this paper
• Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer

  2020cites this paper
• Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer

  2020cites this paper
• Autoantibodies against tumor‐associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma

  2019cites this paper
• Establishment and validation of an immunodiagnostic model for prediction of breast cancer

  2019cites this paper
• Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches.

  2019cites this paper
• Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening

  2019cites this paper
• Characterisation of immune-modulating lymphocyte populations in melanoma patients

  2019cites this paper
• Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection

  2019cites this paper
• Evaluation of a panel of tumor-associated antigens in breast cancer

  2019influential citation
• Using recursive partitioning approach to select tumor‐associated antigens in immunodiagnosis of gastric adenocarcinoma

  2019cites this paper
• Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer

  2019cites this paper
• Electrochemical biosensors for autoantibodies in autoimmune and cancer diseases

  2019cites this paper
• Autoantibodies as biomarkers for colorectal cancer: A systematic review, meta-analysis, and bioinformatics analysis

  2019cites this paper
• Diagnostic value of multiple tumor-associated autoantibodies in lung cancer

  2019cites this paper
• Using a panel of multiple tumor‐associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer

  2018cites this paper
• No evidence of pancreatic ductal adenocarcinoma specific autoantibodies to Ezrin in a liquid phase LIPS immunoassay

  2018cites this paper
• Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis

  2018cites this paper
• Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens

  2018cites this paper
• Developments in Point-of-Care Diagnostic Technology for Cancer Detection

  2018cites this paper
• Preclinical Biomarkers for the Early Detection of Lung Cancer

  2018cites this paper
• Early detection of lung cancer by using an autoantibody panel in Chinese population

  2018cites this paper
• Circulating anti‐p16a IgG autoantibodies as a potential prognostic biomarker for non‐small cell lung cancer

  2018cites this paper
• Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia

  2018cites this paper
• Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells

  2018cites this paper
• Multi-panel assay of serum autoantibodies in colorectal cancer

  2018cites this paper
• Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer

  2018cites this paper
• Development of a novel parallel determination platform: a feasibility study tested on a chemiluminescence device

  2018cites this paper
• The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions

  2017cites this paper
• Gastric Cancer Biomarkers in Circulation

  2017cites this paper
• Impacts of survivin and caspase-3 on apoptosis and angiogenesis in oral cancer.

  2017cites this paper
• Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer

  2017cites this paper
• Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer

  2017cites this paper
• Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia

  2017cites this paper
• Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma

  2017cites this paper
• The crossroads between cancer immunity and autoimmunity: antibodies to self antigens.

  2017cites this paper
• Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection

  2017cites this paper
• BARD1 serum autoantibodies for the detection of lung cancer

  2017cites this paper
• Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer

  2017cites this paper
• Panel of autoantibodies against multiple tumor‐associated antigens for detecting gastric cancer

  2017cites this paper
• Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer

  2017influential citation
• Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer

  2016cites this paper
• Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag

  2016cites this paper
• Autoantibodies against tumor-associated antigens in the early detection of lung cancer.

  2016cites this paper
• Tumour‐Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta‐Analysis

  2016cites this paper
• Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer

  2016cites this paper
• Anti-cytoplasmic Autoantibodies in Hodgkin's Lymphoma.

  2016cites this paper
• Using Serological Proteome Analysis to Identify Serum Anti‐Nucleophosmin 1 Autoantibody as a Potential Biomarker in European‐American and African‐American Patients With Prostate Cancer

  2016cites this paper
• Detection of Autoantibodies by Enzyme-Linked Immunosorbent Assay and Bead Assays

  2016cites this paper
• A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer

  2016cites this paper
• Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma

  2015cites this paper
• Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer

  2015cites this paper
• Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.

  2015cites this paper
• Immunosignature: Serum Antibody Profiling for Cancer Diagnostics.

  2015cites this paper
• Western Blotting

  2015cites this paper
• Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status

  2015cites this paper
• Nontoxic virus nanofibers improve the detection sensitivity for the anti-p53 antibody, a biomarker in cancer patients

  2015cites this paper
• Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack

  2015cites this paper
• A miniaturized blotting system for simultaneous detection of different autoantibodies.

  2015cites this paper
• Evaluation of the humoral immune response against survivin in patients with lung cancer

  2015influential citation
• WITHDRAWN: Dual display bacteriophage as a platform for high sensitive detection of serum p53 antibodies in breast cancer patients.

  2015cites this paper
• An Autoantibody Based Protein Microarray Blood Test to Enhance the Specificity of a Negative Screening Mammogram

  2015cites this paper
• Emerging blood-based biomarkers for detection of gastric cancer.

  2015cites this paper
• Systematic review: Serum autoantibodies in the early detection of gastric cancer

  2015cites this paper
• Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies

  2015cites this paper
• Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma.

  2015cites this paper
• Autoimmune response to PARP and BRCA1/BRCA2 in cancer

  2015cites this paper
• Combating the Epigenome: Elucidation of Mechanisms Underlying Chemoresistance and Enhancing Tumor Immunogenicity

  2015cites this paper
• Diagnostic Potential of Zinc Finger Protein-Specific Autoantibodies and Associated Linear B-Cell Epitopes in Colorectal Cancer

  2015cites this paper
• Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.

  2015cites this paper
• Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.

  2015cites this paper
• Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.

  2014cites this paper
• A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma

  2014cites this paper
• N-glycolyl GM3 as potential target for cancer immunotherapy

  2014cites this paper
• Detection of serum p53 antibodies from Chinese patients with papillary thyroid carcinoma using phage-SP-ELISA: correlation with clinical parameters

  2014cites this paper
• Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.

  2014cites this paper
• Autoantibodies in breast cancer.

  2014cites this paper
• Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens

  2014influential citation
• Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.

  2014influential citation
• Biodegradable particles as vaccine delivery systems

  2014cites this paper